J

JCR Pharmaceuticals Co Ltd
TSE:4552

Watchlist Manager
JCR Pharmaceuticals Co Ltd
TSE:4552
Watchlist
Price: 712 JPY -2.06% Market Closed
Market Cap: 92.3B JPY

Intrinsic Value

The intrinsic value of one JCR Pharmaceuticals Co Ltd stock under the Base Case scenario is 742.19 JPY. Compared to the current market price of 712 JPY, JCR Pharmaceuticals Co Ltd is Undervalued by 4%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
742.19 JPY
Undervaluation 4%
Intrinsic Value
Price
J
Worst Case
Base Case
Best Case

Valuation History
JCR Pharmaceuticals Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about JCR Pharmaceuticals Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is JCR Pharmaceuticals Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for JCR Pharmaceuticals Co Ltd.

Explain Valuation
Compare JCR Pharmaceuticals Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about JCR Pharmaceuticals Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
JCR Pharmaceuticals Co Ltd

Current Assets 55.8B
Cash & Short-Term Investments 15.6B
Receivables 13.6B
Other Current Assets 26.6B
Non-Current Assets 53.2B
Long-Term Investments 10.4B
PP&E 37.1B
Intangibles 2.7B
Other Non-Current Assets 3B
Current Liabilities 47.5B
Accounts Payable 1.1B
Accrued Liabilities 1.4B
Other Current Liabilities 45B
Non-Current Liabilities 13.4B
Long-Term Debt 11.7B
Other Non-Current Liabilities 1.7B
Efficiency

Free Cash Flow Analysis
JCR Pharmaceuticals Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
JCR Pharmaceuticals Co Ltd

Revenue
37.8B JPY
Cost of Revenue
-11.3B JPY
Gross Profit
26.5B JPY
Operating Expenses
-30.2B JPY
Operating Income
-3.7B JPY
Other Expenses
1.3B JPY
Net Income
-2.4B JPY
Fundamental Scores

Profitability Score
Profitability Due Diligence

JCR Pharmaceuticals Co Ltd's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Declining Gross Margin
Low 3Y Average Operating Margin
38/100
Profitability
Score

JCR Pharmaceuticals Co Ltd's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

JCR Pharmaceuticals Co Ltd's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Negative Net Debt
Short-Term Solvency
43/100
Solvency
Score

JCR Pharmaceuticals Co Ltd's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
JCR Pharmaceuticals Co Ltd

Wall Street analysts forecast JCR Pharmaceuticals Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JCR Pharmaceuticals Co Ltd is 667.37 JPY with a low forecast of 555.5 JPY and a high forecast of 756 JPY.

Lowest
Price Target
555.5 JPY
22% Downside
Average
Price Target
667.37 JPY
6% Downside
Highest
Price Target
756 JPY
6% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for JCR Pharmaceuticals Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one JCR Pharmaceuticals Co Ltd stock?

The intrinsic value of one JCR Pharmaceuticals Co Ltd stock under the Base Case scenario is 742.19 JPY.

Is JCR Pharmaceuticals Co Ltd stock undervalued or overvalued?

Compared to the current market price of 712 JPY, JCR Pharmaceuticals Co Ltd is Undervalued by 4%.

Back to Top